![Kuldeep Neote](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kuldeep Neote
Vorstandsvorsitzender bei
Diadem Biotherapeutics, Inc.
Profil
Kuldeep Neote currently works at Diadem Biotherapeutics, Inc., as Chief Executive Officer from 2024 and Accelerate Long Island (Venture Capital), as Investment Review Committee Member.
Dr. Neote also formerly worked at Johnson & Johnson, as Senior Director from 2018 to 2019, New Ventures, Inc. (Washington), as Senior Director from 2013 to 2017, and Eli Lilly & Co., as Vice President from 2019 to 2021.
Dr. Neote received his doctorate degree in 1989 from the University of Toronto.
Aktive Positionen von Kuldeep Neote
| Unternehmen | Position | Beginn |
|---|---|---|
Accelerate Long Island (Venture Capital)
 Accelerate Long Island (Venture Capital) Investment ManagersFinance Accelerate Long Island (Venture Capital) invests in companies located in the United States. The firm targets companies operating across a broad of sectors and industries. It provides financing for seed capital requirements. | Private Equity Investor | - |
Diadem Biotherapeutics, Inc.
 Diadem Biotherapeutics, Inc. BiotechnologyHealth Technology Operates biotechnology company that focuses on creating bio-therapeutically materials produced using organic means | Vorstandsvorsitzender | 01.10.2024 |
Ehemalige bekannte Positionen von Kuldeep Neote
| Unternehmen | Position | Ende |
|---|---|---|
| ELI LILLY AND COMPANY | Berater | 01.04.2013 |
| JOHNSON & JOHNSON | Private Equity Investor | 30.04.2019 |
New Ventures, Inc. (Washington)
 New Ventures, Inc. (Washington) Investment ManagersFinance New Ventures invests in companies located in the United States. The firm focuses on technology, biodiversity, renewable energy and sustainable forestry sectors. It provides financing for early stage capital transactions with an investment size of USD 0.1 million - 5 million. | Private Equity Investor | 30.09.2017 |
Ausbildung von Kuldeep Neote
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
92
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New Ventures, Inc. (Washington)
New Ventures, Inc. (Washington) Investment ManagersFinance New Ventures invests in companies located in the United States. The firm focuses on technology, biodiversity, renewable energy and sustainable forestry sectors. It provides financing for early stage capital transactions with an investment size of USD 0.1 million - 5 million. | Finance |
Accelerate Long Island (Venture Capital)
Accelerate Long Island (Venture Capital) Investment ManagersFinance Accelerate Long Island (Venture Capital) invests in companies located in the United States. The firm targets companies operating across a broad of sectors and industries. It provides financing for seed capital requirements. | Finance |
Diadem Biotherapeutics, Inc.
Diadem Biotherapeutics, Inc. BiotechnologyHealth Technology Operates biotechnology company that focuses on creating bio-therapeutically materials produced using organic means | Health Technology |
Wählen Sie MarketScreener 
